Bright Minds Biosciences Inc.

DRUG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
6-K Nov 2, 2026
6-K Oct 2, 2026 FORM 6-K
6-K Oct 1, 2026 FORM 6-K
6-K Aug 17, 2026 FORM 6-K
SCHEDULE 13G/A Aug 14, 2026
S-8 Aug 13, 2026 FORM S-8
SCHEDULE 13G/A Aug 12, 2026
SCHEDULE 13D/A Jul 2, 2026
6-K Jun 3, 2026 FORM 6-K
6-K Jun 2, 2026 FORM 6-K
6-K May 28, 2026
6-K May 20, 2026 FORM 6-K
SCHEDULE 13G May 15, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 12, 2026
SCHEDULE 13G/A Apr 30, 2026
4 Apr 30, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
6-K Feb 13, 2026 FORM 6-K
SCHEDULE 13G/A Feb 6, 2026
6-K Jan 9, 2026 FORM 6-K
6-K Jan 9, 2026 FORM 6-K
← Newer Page 1 of 8 · 180 filings Older →